Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
- PMID: 30500353
- DOI: 10.1016/j.biotechadv.2018.11.013
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that is a leading cause of morbidity and mortality in cystic fibrosis patients and immunocompromised individuals. Eradication of P. aeruginosa has become increasingly difficult due to its remarkable capacity to resist antibiotics. Strains of Pseudomonas aeruginosa are known to utilize their high levels of intrinsic and acquired resistance mechanisms to counter most antibiotics. In addition, adaptive antibiotic resistance of P. aeruginosa is a recently characterized mechanism, which includes biofilm-mediated resistance and formation of multidrug-tolerant persister cells, and is responsible for recalcitrance and relapse of infections. The discovery and development of alternative therapeutic strategies that present novel avenues against P. aeruginosa infections are increasingly demanded and gaining more and more attention. Although mostly at the preclinical stages, many recent studies have reported several innovative therapeutic technologies that have demonstrated pronounced effectiveness in fighting against drug-resistant P. aeruginosa strains. This review highlights the mechanisms of antibiotic resistance in P. aeruginosa and discusses the current state of some novel therapeutic approaches for treatment of P. aeruginosa infections that can be further explored in clinical practice.
Keywords: Pseudomonas aeruginosa; alternative therapeutics; antibiotic resistance; new antibiotics; resistance mechanisms.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.Am J Respir Cell Mol Biol. 2018 Apr;58(4):428-439. doi: 10.1165/rcmb.2017-0321TR. Am J Respir Cell Mol Biol. 2018. PMID: 29372812 Free PMC article. Review.
-
Antibiotic Resistance in Pseudomonas.Adv Exp Med Biol. 2022;1386:117-143. doi: 10.1007/978-3-031-08491-1_5. Adv Exp Med Biol. 2022. PMID: 36258071
-
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.Adv Drug Deliv Rev. 2015 May;85:7-23. doi: 10.1016/j.addr.2014.11.017. Epub 2014 Dec 2. Adv Drug Deliv Rev. 2015. PMID: 25477303 Review.
-
Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Future Microbiol. 2013. PMID: 23841636 Review.
-
Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In Vivo.mBio. 2021 Jan 12;12(1):e02411-20. doi: 10.1128/mBio.02411-20. mBio. 2021. PMID: 33436433 Free PMC article.
Cited by
-
Molecular Typing of Pseudomonas aeruginosa Isolates Collected in Abidjan Hospitals (Côte d'Ivoire) Using the Multiple-Locus Variable Number of Tandem Repeats Method.Diagnostics (Basel). 2024 Oct 14;14(20):2284. doi: 10.3390/diagnostics14202284. Diagnostics (Basel). 2024. PMID: 39451606 Free PMC article.
-
A novel PhoPQ-potentiated mechanism of colistin resistance impairs membrane integrity in Pseudomonas aeruginosa.bioRxiv [Preprint]. 2024 Oct 16:2024.10.15.618514. doi: 10.1101/2024.10.15.618514. bioRxiv. 2024. PMID: 39464160 Free PMC article. Preprint.
-
Treatment of Pseudomonas aeruginosa infectious biofilms: Challenges and strategies.Front Microbiol. 2022 Aug 26;13:955286. doi: 10.3389/fmicb.2022.955286. eCollection 2022. Front Microbiol. 2022. PMID: 36090087 Free PMC article. Review.
-
Antibiogram profile and virulence signatures of Pseudomonas aeruginosa isolates recovered from selected agrestic hospital effluents.Sci Rep. 2021 Jun 3;11(1):11800. doi: 10.1038/s41598-021-91280-6. Sci Rep. 2021. PMID: 34083705 Free PMC article.
-
Plant-Based Phytochemicals as Possible Alternative to Antibiotics in Combating Bacterial Drug Resistance.Antibiotics (Basel). 2020 Aug 4;9(8):480. doi: 10.3390/antibiotics9080480. Antibiotics (Basel). 2020. PMID: 32759771 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical